Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway
Document Type: Research Article
Affiliations: 1: Department of Cardiothoracic Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, P.R. China 2: Key Laboratory of Cancer Proteomics of the Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha 410008, P.R. China 3: Department of Ultrasound, The Third Xiangya Hospital, Central South University, Changsha 410013, P.R. China
Publication date: March 1, 2014
- Oncology Reports is a monthly, peer-reviewed journal devoted to the publication of high quality original studies and reviews concerning a broad and comprehensive view of fundamental and applied research in oncology, focusing on carcinogenesis, metastasis and epidemiology.
The journal is published in both print and electronic format.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites